0.93

4.12% -0.04

Actinium Pharmaceuticals Inc (ATNM)

Overview News Price History Option Chain Discussions Forecast Stock Split

Actinium Pharmaceuticals Inc stock is traded at $0.93, with a volume of 75,801. It is down -4.12% in the last 24 hours and down -11.43% over the past month. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.

Previous Close:

$0.97

Open:

$0.96

24h Volume:

75,801

Relative Volume:

0.44

Market Cap:

$29.18M

Revenue:

$90,000

Net Income/Loss:

$-23.47M

P/E Ratio:

-1.2364

EPS:

-0.7522

Net Cash Flow:

$-22.98M

1W Performance:

-5.20%

1M Performance:

-11.43%

6M Performance:

-33.09%

1Y Performance:

-40.00%

1-Day Range:

$0.92

$0.975

1-Week Range:

$0.92

$1.05

52-Week Range:

$0.92

$1.89

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name

Actinium Pharmaceuticals Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

646-767-3870

Address

275 Madison Avenue, 7th Floor, New York, NY

Employee

Twitter

@actiniumpharma

Next Earnings Date

2026-08-14

Latest SEC Filings

ATNM's Discussions on Twitter

Compare ATNM vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATNM Actinium Pharmaceuticals Inc	0.93	29.18M	90,000	-23.47M	-22.98M	-0.7522
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-07-24	Downgrade	B. Riley Securities	Buy → Neutral
May-14-24	Initiated	Stephens	Overweight
Sep-06-23	Initiated	HSBC Securities	Buy
Feb-21-23	Downgrade	William Blair	Outperform → Mkt Perform
Sep-08-22	Initiated	Cantor Fitzgerald	Overweight
Aug-25-22	Initiated	B. Riley Securities	Buy
Nov-05-20	Initiated	Alliance Global Partners	Buy
Dec-06-17	Initiated	B. Riley FBR, Inc.	Buy
Oct-23-17	Resumed	ROTH Capital	Buy
Sep-14-17	Initiated	Maxim Group	Buy
Aug-25-16	Initiated	ROTH Capital	Buy
Feb-29-16	Initiated	H.C. Wainwright	Buy
Oct-15-15	Initiated	FBR Capital	Outperform
Oct-01-14	Initiated	MLV & Co	Buy
Jul-22-14	Initiated	Canaccord Genuity	Buy

View All

Actinium Pharmaceuticals Inc Stock (ATNM) Latest News

Jul 10, 2026

Actinium Pharmaceuticals (ATNM) 15th Annual LD Micro Invitational 2025 Summary - Quartr

Jul 08, 2026

Jul 07, 2026

Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - AOL.com

Jul 07, 2026

Actinium Company Profile & Introduction - Moomoo

Jul 07, 2026

Jul 03, 2026

ATNM Should I Buy - Intellectia AI

Jul 03, 2026

ATNMActinium Pharmaceuticals Inc Earnings - Finviz

Jul 03, 2026

Jul 02, 2026

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - The National Law Review

Jul 02, 2026

Jun 27, 2026

ATNM Stockholders Have Opportunity to Lead Actinium Pharmaceutica - The National Law Review

Jun 27, 2026

ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceut - The National Law Review

Jun 27, 2026

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Joi - The National Law Review

Jun 27, 2026

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Jun 27, 2026

Levi & Korsinsky Notifies Shareholders of Actinium Pharmaceutical - The National Law Review

Jun 27, 2026

Jun 26, 2026

Enterprise value to revenue forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView

Jun 26, 2026

Price to sales forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView

Jun 26, 2026

Price to earnings forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView

Jun 26, 2026

Price to book forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView

Jun 26, 2026

Jun 25, 2026

Actinium Pharmaceuticals, Inc. Actuals & Estimates (AMEX:ATNM) - TradingView

Jun 25, 2026

ATNM Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026